4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001935668-26-000002
Options or other derivatives
- Director acquired 25,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ben Zvi Shmuel Director | 2026-09-03 | Grant or award · Stock Options (Right to Buy) | +17,000 | 17,000 | D | ||
| Ben Zvi Shmuel Director | 2026-09-03 | Grant or award · Restricted Stock Units | +8,500 | 8,500 | D | ||
Loading xslF345X06/form4-09042026_060909.xml…